Governor lauds Virginia Tech Carilion Research Institute’s biomedical research programs

Governor Terry McAuliffe
Governor Terry McAuliffe speaking at the 2014 PhRMA Annual Meeting in Washington, DC, on April 11

Virginia Governor Terry McAuliffe recently cited the Virginia Tech Carilion Research Institute as a model of collaboration between public and private partners.

“We know that our efforts to promote productive collaborations are now working,” the governor said, speaking at the 2014 PhRMA Annual Meeting in Washington, DC, on April 11. “Our Virginia Tech Carilion Research Institute in Roanoke is a great example of what you can do with collaboration.”

After noting the roles of the commonwealth, Virginia Tech, and Carilion Clinic in co-founding the institute, McAuliffe added, “This research institute is driving Virginia to fast becoming a world leader in brain research.”

He mentioned the innovative new Catalyst program, in which the state provides support for collaborative research between multiple universities and private companies in Virginia.

The governor went on to describe one of the institute’s premier research initiatives as an example of successful collaborations.

“VTCRI is now the hub of the world’s only network of over one dozen MRI machines used to perform functional brain scanning,” he said. “This network is used to perform hyperscanning, scanning multiple individuals in sites across the world simultaneously. Developed by Professor Read Montague, this invention is providing unprecedented insight into how the human brain functions. It will change the way we understand and diagnose conditions such as autism, Alzheimer’s, and addiction.

“This is just one exciting example of what happens,” McAuliffe concluded, “when institutions come together in Virginia to collaborate.”

“It’s an honor to have the governor recognize the institute’s work, including our growing programs and impact in brain research,” said Michael Friedlander, executive director of the Virginia Tech Carilion Research Institute. “The support of the state’s leadership facilitates the work of the institute’s scientists as they work tirelessly to develop new diagnostics, treatments, and cures.”